Monitoring schedule Healthcare providers who specialize in GLP-1 therapy typically recommend this monitoring cadence: Baseline: Full B12 panel before starting semaglutide 3 months: Repeat serum B12 and MMA 6 months: Full panel reassessment Annually: Once stable, annual monitoring is usually sufficient For high-risk patients (metformin users, vegans, those over 60, post-bariatric surgery), the 3-month check is particularly important
Each request can take days to weeks for a decision, during which the patients therapy is deferred
For the dosing-math side of working with retatrutide as a research compound, our retatrutide dosage chart and reconstitution reference covers the same molecule from the bench side: reconstitution math, molar concentrations, storage windows, and the human-trial doses laid out as a reference-only table
Your personal Wegovy treatment plan should reflect your goals, and if you intend to lose a lot of weight, you may need to use higher doses